To decouple the STING pathway-mediated therapeutic effect from the direct tumor-killing effect of LID + US, we examined the therapeutic effect of LID + US on STING knockout (STING KO) mice bearing subcutaneous MC38 tumors. The gene discussed is STING1; the disease is neoplasm.